Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 812 results for "daiichi sankyo"

Sun Pharmaceutical wins US approval to acquire Ranbaxy
India Infoline

Sun Pharmaceutical wins US approval to acquire Ranbaxy

Earlier in April, Sun Pharmaceutical said that it had agreed to Ranbaxy from its current owner, Japan's Daiichi Sankyo Co, for $3.2 billion Sun Pharmaceutical Industries Ltd has won US approval to acquire Ranbaxy Laboratories Ltdon condition that it sell its ... India Infoline, 1 month ago
Sun-Ranbaxy deal gets FTC nod Deccan Herald, 1 month ago

18 images for daiichi sankyo

Mobihealthnews, 3 days ago
Japan Times, 3 weeks ago
MSN News, 1 month ago
Lawyer Herald, 1 month ago
Yahoo! News, 1 month ago
Yahoo! News Australia, 1 month ago
Yahoo! News, 1 month ago
Social Dashboard, 1 month ago
KXXV-TV, 1 month ago
Yahoo! News, 1 month ago
Mobihealthnews

Why Partners and Daiichi Sankyo partnered on an AFib remote patient monitoring pilot

Greg Barrett, VP Marketing and Managed Markets at Daiichi Sankyo The partnership between Daiichi Sankyo and Partners HealthCare's Center for Connected Health to bring mobile device monitoring to atrial fibrillation patients is still in its early ...
 Mobihealthnews3 days ago Japan's Daiichi Sankyo revamps operations, management, ahead of olmesartan expiry  Fierce CRO1 week ago Daiichi Sankyo Company, Ltd Files SEC Form SC 13G, Statement of Acquisition of Beneficial Ownership By Individuals (Feb. 17, 2015)  Insurance News Net1 week ago Daiichi Sankyo Appoints New Group Corporate Officers  Noodls1 week ago
[x]  

DAIICHI SANKYO : Details Findings in Organic Research (Synthesis of an alpha-Amylase Inhibitor: Highly Stereoselective Glycosidation and Regioselective...

Daiichi Sankyo Details Findings in Organic Research (Synthesis of an alpha-Amylase Inhibitor: Highly Stereoselective Glycosidation and Regioselective Manipulations of Hydroxyl Groups in Carbohydrate Derivatives) By a News Reporter-Staff News ...
 4 Traders2 days ago Daiichi Sankyo Announces Organizational Restructuring as of April 1, 2015  FierceBiotech1 week ago DAIICHI SANKYO : Announces Organizational Restructuring as of April 1, 2015  4 Traders1 week ago
Reuters

Daiichi Sankyo to pay $39 million to settle U.S. kickback claims: DOJ

(Reuters) - The U.S. subsidiary of global pharmaceutical company Daiichi Sankyo Co Ltd has agreed to pay $39 million to the U.S. government and state Medicaid programs to settle claims it paid doctors kickbacks to prescribe its drugs, the Department of ...
 Reuters1 month ago

DAIICHI SANKYO : Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit

As the Mayo Clinic's 2012 published Benicar case study findings continue to be discussed, Ford & Associates Nationwide Legal Services, A.P.C., comments on these findings in wake of a January 2015 filed lawsuit: Verduzco v. Daiichi Sankyo, Inc. , ...
 4 Traders20 hours ago Mayo Clinic's Benicar Case Study Findings Prompts Commentary...  San Francisco Chronicle12 hours ago
[x]  

Edoxaban: Fourth novel oral anticoagulant approved

In January, Daiichi Sankyo announced FDA approval of edoxaban (Savaysa), a factor Xa inhibitor, for the reduction of stroke risk in patients with nonvalvular atrial fibrillation (AF) and for the treatment of venous thromboembolism (VTE) and ...
 Pharmacist.com5 days ago U.S. FDA approves Daiichi anti-clotting drug  Reuters1 month ago

Atrial Fibrillation Treatment Market in 8MM Epidemiology Forecast to 2023

RnRMarketResearch.com adds "EpiCast Report Atrial Fibrillation - Epidemiology Forecast to 2023" report to its store. The report provides an overview of the risk factors, comorbidities, and the global and historical trends for AF in the eight major ...
 Wall Street Select1 day ago
[x]  

Treating your type 2 diabetes?

For the millions of Americans living with type 2 diabetes, a combination of diet, exercise and medication can help them control the condition. But even those who are doing everything right to manage their diabetes may be at higher risk of developing ...
 The Suit Magazine8 hours ago

TeraRecon fortalece su posiciĀ³n en EMEA

(Date:3/6/2015)... AbbVie (NYSE: ABBV ) will participate ... March 12, 2015. Richard A. Gonzalez , chairman ... and answer session at 8:30 a.m. Central time. ... be accessible through AbbVie,s Investor Relations Web site at ... will be available ...
 Bio-Medicine14 hours ago

DKSH Expands Asian Market for Sumitomo Dainippon Pharma

/PRNewswire/ -- DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, will provide marketing, sales and regulatory services as well as distribution and logistics for lurasidone ...
 Yahoo! Finance1 day ago DKSH : expands Asian market for Sumitomo Dainippon Pharma  4 Traders1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less